Giovanni Pallabazzer

ORCID: 0000-0003-2495-7635
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gastric Cancer Management and Outcomes
  • Esophageal and GI Pathology
  • Esophageal Cancer Research and Treatment
  • Cancer Genomics and Diagnostics
  • Gastroesophageal reflux and treatments
  • RNA modifications and cancer
  • Dysphagia Assessment and Management
  • Molecular Biology Techniques and Applications
  • Genetic factors in colorectal cancer
  • Gastrointestinal Tumor Research and Treatment
  • Helicobacter pylori-related gastroenterology studies
  • Cancer Research and Treatments
  • Cancer Cells and Metastasis
  • Lung Cancer Treatments and Mutations
  • Metastasis and carcinoma case studies
  • Eosinophilic Esophagitis
  • Lung Cancer Diagnosis and Treatment
  • Cytokine Signaling Pathways and Interactions
  • Digestive system and related health
  • Immune Cell Function and Interaction
  • MicroRNA in disease regulation
  • Cancer Immunotherapy and Biomarkers
  • Bariatric Surgery and Outcomes
  • Intestinal Malrotation and Obstruction Disorders
  • Pancreatitis Pathology and Treatment

Azienda Ospedaliera Universitaria Pisana
2013-2024

Regione Toscana
2011-2019

Ospedale Cisanello
2015-2019

University of Pisa
2013-2019

Azienda Socio Sanitaria Territoriale di Bergamo Ovest
2018

Azienda Ospedaliera Treviglio
2018

University of Perugia
2016

Christie's
2016

Creative Commons
2016

Ospedale Santa Chiara
2011

Abstract Gastric cancer is the world's third leading cause of mortality. In spite significant therapeutic improvements, clinical outcome for patients with advanced gastric poor; thus, identification and validation novel targets extremely important from a point view. We generated wide, multilevel platform models, comprising 100 patient-derived xenografts (PDX), primary cell lines, organoids. Samples were classified according to their histology, microsatellite stability, Epstein–Barr virus...

10.1158/0008-5472.can-19-1166 article EN Cancer Research 2019-10-04

Patient-Derived Xenografts (PDXs), entailing implantation of cancer specimens in immunocompromised mice, are emerging as a valuable translational model that could help validate biologically relevant targets and assist the clinical development novel therapeutic strategies for gastric cancer. More than 30% PDXs generated from carcinoma samples developed human B-cell lymphomas instead These were monoclonal, Epstein Barr Virus (EBV) positive, originated tumorigenic cell cultures displayed...

10.1016/j.neo.2018.02.003 article EN cc-by-nc-nd Neoplasia 2018-03-23

Abstract Coronavirus Disease-19 (COVID-19) outbreak has significantly burdened healthcare systems worldwide, leading to reorganization of services and reallocation resources. The Italian Society for Study Esophageal Diseases (SISME) conducted a national survey evaluate changes in esophageal cancer management region severely struck by COVID-19 pandemic. A web-based questionnaire (26 items) was sent 12 SISME units. Short-term outcomes resections performed during the lockdown were compared with...

10.1093/dote/doaa124 article EN other-oa Diseases of the Esophagus 2020-11-27

To investigate the prognostic value of tumor metabolism measurements on serial 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and computed scans in patients with locally advanced esophageal cancer undergoing neoadjuvant chemoradiotherapy. Forty-five (63 ± 7 years, 6 female) treated concomitant chemoradiotherapy before surgery were followed up for 24 18 months (range 4–71). Positron obtained within 1 week start (PET1) month after completion treatment (PET2). Total body metabolic...

10.1097/md.0000000000003151 article EN cc-by-nc Medicine 2016-03-01

Abstract Background The effectiveness of bariatric surgery for weight loss in morbidly obese patients has been well established and it's becoming more common as many surgeons are trained to perform them safely, even older patients. Obesity is associated with reflux hormonal imbalances that increase the risk Barrett's esophagus, esophageal adenocarcinoma gastric cancer. Bariatric procedures alter anatomy, vascularization lymphatic drainage render subsequent upper gastrointestinal malignancies...

10.1093/dote/doae057.383 article EN other-oa Diseases of the Esophagus 2024-09-01

Abstract Background Epiphrenic esophageal diverticula are rare and often associated with motor disorders. Surgery is reserved for larger symptoms that significantly impair quality of life. When possible, a transhiatal approach can reduce pulmonary complications by preserving pleural integrity; more proximal diverticular openings require combined transthoracic abdominal to achieve complete excision. Robotic surgery assists in precise dissection preservation delicate mediastinal structures....

10.1093/dote/doae057.376 article EN other-oa Diseases of the Esophagus 2024-09-01

Abstract Aim This paper is a case report about patient with esophageal adenocarcinoma that occurred many years after laparoscopic sleeve gastrectomy (LSG), highlighting the technical difficulties an esophagectomy bariatric surgery entails. Background and methods Esophagectomy for cancer complex operation than can be associated significance morbidity mortality. Options include either partial intrathoracic (Ivor-Lewis resection) or total neck anastomosis (three field technique described by...

10.1093/dote/doz092.212 article EN Diseases of the Esophagus 2019-11-01

<div>Abstract<p>Gastric cancer is the world's third leading cause of mortality. In spite significant therapeutic improvements, clinical outcome for patients with advanced gastric poor; thus, identification and validation novel targets extremely important from a point view. We generated wide, multilevel platform models, comprising 100 patient-derived xenografts (PDX), primary cell lines, organoids. Samples were classified according to their histology, microsatellite stability,...

10.1158/0008-5472.c.6511170 preprint EN 2023-03-31

<div>Abstract<p>Gastric cancer is the world's third leading cause of mortality. In spite significant therapeutic improvements, clinical outcome for patients with advanced gastric poor; thus, identification and validation novel targets extremely important from a point view. We generated wide, multilevel platform models, comprising 100 patient-derived xenografts (PDX), primary cell lines, organoids. Samples were classified according to their histology, microsatellite stability,...

10.1158/0008-5472.c.6511170.v1 preprint EN 2023-03-31
Coming Soon ...